SMAD1/5/8/9 Antibody

SMADs are members of the MAD-related family of molecules. MAD-related proteins are a family of intracellular proteins that are essential components in the signaling pathways of the serine/threonine kinase receptors of the transforming growth factor beta superfamily (1). SMADs can be divided into receptor-regulated SMADs (R-SMADs: SMAD1, 2, 5, 8 and 9), common-mediator SMAD (co-SMAD: SMAD4), and inhibitory SMADs (I-SMADs: SMAD6 and 7). SMAD1, 5, 8 and 9 have high degrees of homology and antibodies are available that recognize sequences common to all of them.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 1 application: WB.

Showing Publications 1 - 3 of 3.

Publications using NB100-56656	Applications	Species
Li D, Zhang D, Yuan Q et al. In vitro and in vivo assessment of the effect of biodegradable magnesium alloys on osteogenesis Acta biomaterialia 2021-12-28 [PMID: 34971787] (WB, Human)	WB	Human
Zhao X, Sun Q, Dou C et al. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression Front Biosci (Landmark Ed) 2019-03-01 [PMID: 30844730]
Iyer S, Chhabra Y, Harvey TJ et al. CRIM1 is necessary for coronary vascular endothelial cell development and homeostasis. J. Mol. Histol. 2016-11-01 [PMID: 27803996] (Mouse)		Mouse

Array NB100-56656

• SMAD1/5/8/9 Antibodies